In addition, others identified HLA-DRB1*0401 and HLA-DP4 restricted epitopes in the carboxy-terminal end of NY-ESO-1 which can be recognized by CD4+ T lymphocytes from melanoma patients (66–69). Here, CTAG1B is linked to melanoma.